Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05741489 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes

A NA study of End-Stage Kidney Disease, sponsored by Emory University.

Completed
Registry status
NA
Development phase
40
Enrollment target
4
Study locations

NCT05741489 is a NA study of End-Stage Kidney Disease that has completed, run by Emory University. The registered enrollment target is 40 participants, below the 464-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05741489, a NA study of End-Stage Kidney Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
4
Study locations

Study Summary

Twenty participants with end stage kidney disease (ESKD) and burnt-out diabetes, and 20 non-diabetic participants with ESKD will wear a continuous glucose monitoring (CGM) device for 10 days to see if the use of CGM is a better tool to assess glycemic control than glycosylated hemoglobin (HbA1c) in patients with ESKD on dialysis.

Conditions Studied

End-Stage Kidney Disease

Interventions

  • DEVICE Continuous glucose monitoring (CGM)

Study Locations (4)

Georgia

  • Grady Memorial Hospital - Atlanta
  • Emory Dialysis at Northside - Atlanta
  • Emory Dialysis at Greenbriar - Atlanta
  • Emory Dialysis at Candler - Decatur

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-08-10
Est. Completion 2023-03-09
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05741489

The ClinicalTrials.gov registry entry for NCT05741489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 464-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (91% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End-Stage Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitoring (CGM) is the first listed.

NCT05741489 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05741489 about?

NCT05741489 is a clinical study titled "Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes". Twenty participants with end stage kidney disease (ESKD) and burnt-out diabetes, and 20 non-diabetic participants with ESKD will wear a continuous glucose monitoring (CGM) device for 10 days to see if the use of CGM is a better tool to assess glycemic control than glycosylated hemoglobin (HbA1c) in ...

What is the current status of trial NCT05741489?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-08-10. Estimated completion is 2023-03-09.

What conditions does trial NCT05741489 study?

This clinical trial studies the following conditions: End-Stage Kidney Disease.

What interventions are being tested in trial NCT05741489?

The interventions under investigation include: Continuous glucose monitoring (CGM) (DEVICE).

Who is sponsoring clinical trial NCT05741489?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05741489 being conducted?

This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End-Stage Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End-Stage Kidney Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.